R. Bryan Bell, MD, DDS, FACS, FRCS(Ed) is a head and neck oncologic surgeon whose clinical activity, teaching and research is devoted primarily to the comprehensive surgical management of patients with head and neck cancer. Dr. Bell currently serves as Physician Executive, Providence Health and Services-Oregon and is Director of the Division of Surgical Oncology, Radiation Oncology and Clinical Programs for the Providence Cancer Institute. He is also Co-Director of the Providence Head and Neck Cancer Program and Clinic, where he oversees a multidisciplinary team dedicated to patients with head and neck cancer. An Associate Member of the Earle A. Chiles Research Institute in the Robert W. Franz Cancer Center, his research efforts are currently focused on immunotherapy to enhance the effectiveness of surgery. Using his surgical practice to run phase I and phase II trials studying reversal of immunosuppression with monoclonal antibodies, Dr. Bell bridges basic, translational and clinical activities. Dr. Bell's work has resulted in over 150 scientific articles and book chapters, and he is co-editor of two major textbooks, including Oral, Head and Neck Oncology and Reconstructive Surgery. He has given more than 200 invited lectures, highlighting his clinical and research interests. Dr. Bell has been appointed or elected to leadership positions in numerous professional societies, boards, foundations and committees, including the National Institutes of Health. Among his many honors, Dr. Bell is a recipient of the William F. Harrigan Award for major contributions to surgery and has been awarded Fellowship in the Royal College of Surgeons of Edinburgh (ad hominem).